SHPH
NASDAQ
$0.53
Shuttle Pharmaceuticals Holdings Inc (SHPH)
Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development and commercialization of drugs to sensitize cancers to radiation therapy. The company is headquartered in Rockville, Maryland.
Sector:
Healthcare
Market Cap
$2.89M
P/B Ratio
0.91
Beta (5Y)
0.14
Price Chart
Valuation
Market Cap$2.89M
P/B0.91
Profitability
EBITDA-$10M
EPS-$7.04
Growth & Risk
Beta (5Y)0.14
Sharpe Ratio-0.98